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Abstract 
Individuals who deal with depression are typically prescribed antidepressants in order to 
alleviate the depressive symptoms that they may be having.  Polysomnographic sleep research 
has revealed that depression is associated with altered sleep architecture and distorted REM sleep 
quality.2  Specifically, increased REM sleep duration and density have proved to be markers that 
predict recurrence and relapse for depressed individuals.  REM sleep serves to stimulate regions 
of the brain that are important with learning and memory consolidation.  However, an increased 
duration of REM sleep in depressed individuals proves to be unfavorable.  Antidepressants drugs 
aim to weaken sleep quality, which is mainly due to increased noradrenergic or dopaminergic 
neurotransmission and the activation of serotonergic 5-HT2 receptors.
4  Therefore, different 
classes of antidepressants have been developed to dampen REM sleep duration and density.  Of 
course, this must be accomplished without determinantal effects for neuronal signaling within 
the brain.  Selective serotonin reuptake inhibitors (SSRI), norepinephrine reuptake inhibitors 
(NRI), activating tricyclic antidepressants (TCA), serotonin and norepinephrine reuptake 
inhibitors (SNRI), and monoamine oxidase antidepressants (MAOI) are most commonly used in 
today’s society.  Current knowledge about antidepressants and their effects on REM sleep are 
explored in this review. 
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Sleep Cycle Overview 
There are a few mechanisms that control sleeping periods in living organisms.  First off, 
the molecule adenosine is produced by the degradation of adenosine triphosphate (ATP).  The 
accumulation of adenosine during wakefulness is associated with the depletion of ATP reserve 
storages in the brain.  This, along with your circadian rhythm, will trigger sleep. 
A sleep cycle is the progression of someone to complete four different stages of sleep.  
Non-rapid eye movement (NREM) sleep is characterized by three different stages of sleep 
ranging from light to deep sleep.  Light sleep is considered Stage 1 and Stage 2 of NREM sleep 
and deep sleep is defined to be Stage 3 of NREM sleep.  Lastly, rapid-eye movement (REM) 
sleep is the final stage of the sleep cycle, which sleepers will display rapid eye movements and 
faster breathing and pulse.  The first cycle typically will run 90 minutes in length, but will 
increase after as a normal sleep cycle lasts between 100-120 minutes.  A typical person will 
complete four to five sleep cycles a night.  Additionally, it is recommended that young adults get 
seven to nine hours of sleep.10   
 NREM sleep is the longest stage of the sleep cycle.  Stage 1 is the lightest stage of the 
sleep cycle, and during this stage, it is often easy to be awakened by external sources.  Brain 
activity slowly declines and many bodily processes begin to relax as the person is beginning to 
fall into heavier sleep.30 
 Stage 2 of NREM sleep is harder to be awakened than stage 1 of NREM sleep.  Stage 2 
of NREM sleep is the first defined cycle of NREM sleep as sleep spindles and K complexes 
begin to form in the brain.  Slowly brain waves will decline as K complexes and sleep spindles 
begin to rapidly fire.  Both of these brain activity waves serve as protection to awaken from sleep 
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in the middle of the night.  In addition to this brain activity, heart rate starts to slow and body 
temperature decreases.   
 The final stage of NREM sleep, known as deep sleep, is unique as delta waves are present 
throughout the brain.  It is very difficult to awaken a person who is in the third stage of NREM 
sleep.  Human growth hormone is released and attempts to restore bodily processes during 
NREM sleep.  The immune system will also replenish helper T cells and muscles throughout the  
body to be restored.16 
 Most of the dreams that individuals experience occurs during REM sleep, which is 
known as the fourth and final stage of the sleep cycle.  Brain waves are the most active during 
this stage as well, along with movements of the eye that are rapid.  REM sleep stimulates regions 
of the brain that are important with learning and also is important in memory consolidation.25   
 
Antidepressant Effects on Sleep 
 Studies have shown that improvements in depression have been correlated with patients 
having reduced amounts of REM sleep.  Antidepressants are often given to patients struggling 
with depression, as most antidepressants significantly reduce REM sleep.  But, antidepressants, 
don’t just reduce REM sleep.  In addition, many of them also alter the sleep architecture of the 
patient and affect sleep consolidation.9  The effects of these antidepressants is important for 
clinical response. 
 Antidepressants drugs weaken sleep quality, which is mainly due to increased 
noradrenergic or dopaminergic neurotransmission and the activation of serotonergic 5-HT2 
receptors.13  The most common antidepressant drugs are known as selective serotonin reuptake 
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inhibitors (SSRI), activating tricyclic antidepressants (TCA), serotonin and norepinephrine 
reuptake inhibitors (SNRI), and monoamine oxidase antidepressants (MAOI).22 
 On the other hand, antidepressants that have a strong antagonistic action at serotonin 5-
HT2 receptors (nefazodone and trazodone) rapidly improve sleep.  Sedating TCA, mianserine, 
and mirtazapine are examples of antidepressants that have antihistaminergic action.  Some 
patients have particularly described improvement of sleep quality within the first dose of the 
drug given.3 
 Studies look to outline parameters of sleep continuity, which has a framework that 
models sleep latency, total sleep time, sleep efficiency, wake after sleep onset, parameters of 
sleep depth, and parameters of REM sleep.  Parameters of sleep depth monitors total and relative 
amounts of stage N3 sleep and delta sleep ratio.  In addition, parameters of REM sleep examine 
REM latency, total and relative amounts of stage REM sleep, and REM density.6  Hypnograms 
are typically used in studies to observe changes in sleep stages in depressed patients.  
Disturbances of sleep continuity, reduction of sleep, and disinhibition of REM sleep with 
shortening of REM latency and prolonged first REM period are characteristic of sleep in 
depression.12 
 The sleep architecture of a patient being tested is critical to determining the efficacy of 
the drug being tested.  The first parameter of sleep continuity that is measured is sleep latency.  
This is known as the time from the start of recording to onset of sleep for the patient.  Total sleep 
time (TST) reflects the total time the patient is sleeping.  Additionally, sleep efficiency is noted 
as the percentage of time spent asleep during the recording period.  Values are typically 85% in 
elderly patients, and 90% in younger children.  Wake after sleep onset (WASO) should be scored 
as the time the patient is awake after sleep onset has occurred.  For experimental purposes, this 
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time should not exceed 30 minutes.  Another parameter looks at total and relative amounts of 
stage NREM3 (N3) sleep and it is the total amount of time and relative percentage of sleep 
occurring in NREM stage 3 sleep.  Studies label delta sleep ratio as the amount of slow wave 
sleep that occurs during the first and second sleep cycles.  The amount of time from the onset of 
sleep to the first cycle of REM sleep that occurs for the patient is defined as REM latency as 
well.  Another parameter of REM sleep describes the total and relative amount of stage REM 
sleep and is expressed in as the duration in minutes and percentage relative to total sleep time in 
REM sleep.  Lastly, REM density reflects the ratio of the intensity of rapid eye movements 
phasic activity to the amount of time in REM sleep.  This value is typically expressed as the 
number of eye movements seen per minute of REM sleep.32 
   
 
Table 1. Effects of antidepressants on sleep are outlined by drug class, sleep continuity, SWS, 
REM latency, REM sleep, and mechanism of action. 
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Tricyclics 
 One of the most known classes of antidepressants is tricyclic antidepressants, which are 
known to be potent suppressors of REM sleep.7  In addition, this class of antidepressants is 
important in decreasing the amount of time someone is in REM sleep and prolongs REM latency. 
Tricyclic antidepressants prolong REM latency, meaning the patient takes longer to transition 
into REM sleep.15  The most potent of the REM-suppressing TCAs are desipramine and 
clomipramine.  These TCAs increase stage 1 sleep, and overall, decrease the quality of sleep for 
the patient.  A stronger serotonergic reuptake that has been shown to have inhibiting effects have 
the most effects on sleep.  Desipramine accomplishes this by elevating noradrenaline at targets of 
the locus coeruleus and have a side effect profile that is limited.  Cholinergic pontine neurons are 
inactivated via desipramine, ultimately leading to inhibition of REM sleep.21     
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Figure 1. Consolidation and reconsolidation effects induced by desipramine. A. Effect of 
10mg/kg desipramine on errors per lap in a spatial maze relative to control. B. Relationship 
between REM sleep and performance in maze reconsolidation task. C. Relationship between TR 
sleep during DMI treatment and performance on familiar maze. D. Effect of 10mg/kg of 
desipramine on errors per lap in novel maze. E. Change in percentage of TR and novel maze 
performance relationship.  F. Correlation of REM and TR sleep states during DMI testing. 
 This study showed that in depressed individuals, DMI that was taken orally reduced REM 
sleep for 5 to 8 hours.  The 10 mg/kg desipramine dose in the eight subjects resulted from an 
average time in 12 h light phase sleep that went from 8.35 ± 1.24% to 3.51 ± 1.22%.  REM sleep, 
in addition, was consistent across all testing days when t tests were paired on first and last days.  
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This would suggest that no REM sleep adaptation was present with administration of 
desipramine. 
 
Monamine Oxidase Inhibitors 
 One of the first class of antidepressants that were developed were monoamine oxidase 
inhibitors.  Monoamine oxidase breaks down dopamine, serotonin, and norepinephrine.  REM 
sleep can also be outright eliminated in some patients if they are prescribed a monoamine 
oxidase inhibitor.  However, this means that the patient will encounter a significant REM 
rebound when weaned off the antidepressant.  Moclobemide, a known MAOI, is thought to 
enhance REM sleep and decreases REM latency.  Not all monoamine oxidase inhibitors have the 
same effects for example.  When 450mg was given to the patient every day for four weeks, 
moclobemide was shown to increase wakefulness, increase sleep latency, and decrease total 
sleep time for the patient.  Moclobemide has been shown in many studies to enhance REM sleep, 
but other studies have concluded that the MAOI has suppressed REM sleep. 
 A study conducted in 2018 in adult male rats look at the effect of tranylcypromine, a 
known monoamine oxidase inhibitor.  A decrease in REM sleep and dizziness was shown in the 
rats, along with leading to severe hypotension.  The total amount of time in REM sleep was 
decreased and a longer time of REM sleep latency was found.  Tranylcypromine acts as an 
irreversible inhibitor and is nonselective.7 
 
Selective Serotonin Reuptake Inhibitors 
 The first known selective serotonin reuptake inhibitor (SSRI), fluoxetine, was developed 
and brought to the United States in 1988.  Since then, studies have been conducted to determine 
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its efficacy.  At the time, fluoxetine was the most available antidepressant and its selectivity for 
specific serotonin receptors made it the ideal SSRI of choice.9  Fluoxetine side effects can 
include skin reactions, but this side effect can’t be eliminated due to the fact that reducing the 
dose of the SSRI will have no effect.  More of the neurotransmitter that it is available to interact 
with is accomplished by the increase of inhibition of serotonin reuptake.  5-HT3 receptors are 
stimulated when SSRI therapy is initiated on a patient, but this side effect can be combated by 
reducing the dose of the SSRI. 
 The most common symptom that is developed when a patient is taking an SSRI is nausea.  
Other frequent side effects via SSRI therapy includes gastrointestinal disturbances.  Fluvoxamine 
is another common SSRI whose most frequent side effect includes gastrointestinal disturbances, 
while other SSRIs like fluoxetine and sertraline side effects commonly include insomnia, 
agitation, and anxiety.  Also, the most adverse effects of being on SSRI therapy can have 
implications on weight gain, sexual dysfunction, and sleep disturbance.   
 Many studies have proved to show that weight gain can be a possible side effect with the 
long term use of SSRIs.  During initial therapy, some SSRIs were associated with weight loss.  
But, after long term use, weight is often regained or six months after use.  On average, patients 
on fluoxetine gained 21 pounds, those on sertraline gained 15 pounds, and those on paroxetine 
gained 24 pounds.  Subtle differences may not show direct causation, but the data behind the 
long term use of these SSRIs points that these values are significant.  Citalopram has been shown 
to least likely cause a weight gain from long term use, but, a great deal of patients report having 
mood and anxiety disorders within five weeks of SSRI therapy. 
 The mechanisms behind to why SSRIs can directly affect sexual dysfunction are not 
completely known.  However, researchers believe that it can be possibly affecting patients due to 
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nitric oxide.  This is due to the stimulation of the postsynaptic 5-HT2 receptors located on the 
spinal cord.  Sexual dysfunction can vary greatly across genders due to the obvious biological 
differences.27  Roughly 2 to 7 percent of patients report sexual side effects when on SSRI 
therapy, so the side effects appear to be minimal.  However, when patients are given a sexual 
dysfunction questionnaire, these numbers change significantly.  55 percent of patients report 
sexual dysfunction through the use of SSRI therapy.  This enormous difference speaks to the fact 
that most patients are not always comfortable speaking about these topics with their physicians.  
Because of this discrepancy, it is suggested the physicians obtain a sexual function history of 
their patients before starting their patient on SSRI therapy. 
  The Hamilton Depression Rating Scale provides a way to determine a patient’s level of 
depression before, during, and after treatment of a certain antidepressant.  An interview is 
conducted via the researcher and is scored on a 5-point scale, ranging from 0 (not present in the 
individual) to 4 (severe).  The SDS Zung Self-Rating Depression Scale attempts to cover 
physiological, affective, and somatic symptoms associated with depression.  It is based on a 20-
item self-report questionnaire and is framed in positive/negative statements.  Each item is scored 
on a 1 to 4 Likert scale with a score of 50-60 indicating depression and 70+ outlining severe 
depression.  The AIS Athens Insomnia Scale assess insomnia symptoms in individuals with sleep 
disorders.  The scale is based on eight factors which cover problems with nocturnal sleep and 
daytime dysfunction.  Score are then rated on a 0-3 scale indicating no problem present or very 
delayed/not sleeping at all. Lastly, CGI-S Clinical Global Impression - Severity Scale assesses a 
severity aspect of a patient’s illness. The Severity Scale is based on a 7-point scale with 1 being 
normal to 7 displaying the most extremely ill patients.  The clinician is asked to rate the severity 
of the patient’s illness with past experience of patients who have underwent the same diagnosis. 
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Table 2. Clinical efficacy outcomes for all patients.  HDRS 17-Item Hamilton Depression Rating 
Scale, SDS Zung Self-Rating Depression Scale, AIS Athens Insomnia Scale, CGI-S Clinical 
Global Impression- Severity Scale.  Mirtazapine is a noradrenergic and specific serotonergic 
antidepressant while sertraline and paroxetine and selective serotonin reuptake inhibitors. 
 
This study conducted by Tasuku Hashimoto and his team aimed to evaluate if 
mirtazapine could be used as a first choice for depressive episodes instead of SSRIs on 
benzodiazepine use in patients diagnosed with major depressive disorder.  HDRS scores between 
mirtazapine and SSRI groups were not statistically significant, as well as changes within the AIS 
and CGI-S scores.  SDS scores of paroxetine and mirtazapine reflects that SDS scores of the 
mirtazapine group showed significant improvement than those of the paroxetine group in the 
week-to-week trials.8 
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In a study completed McCarthy and his colleagues, the researchers looked at well-known 
SSRIs and how they compare to a known TCA.  51 rats were observed as the changes in REM 
sleep observed in major depressive disorder are similar to the effects of REM sleep restricted 
sleep in humans and animals.  The two SSRIs, known as citalopram and paroxetine showed that 
REM sleep inhibition by these antidepressants was unaltered by the presence of REM sleep 
pressure.  NREM sleep time was also fully compensated in the citalopram and paroxetine treated 
group.  On the other hand, the TCA imipramine showed a complete recovery adding to the 
response to prior REM sleep restriction.  Imipramine REM restriction showed that NREM sleep 
time was reduced and not fully compensated up to 36 hours post treatment.  SSRIs also may 
inhibit REM sleep by reducing NREM to REM transitions.  This is accomplished without 
altering the lengths of time of NREM sleep.  Imipramine extends NREM sleep time, which 
induces greater sensitization and a byproduct of a reduced opportunity for REM sleep.  During 
the recovery period, however, this leads to an increase in REM sleep.17   
 
Serotonergic Antidepressants 
 The classification of other serotonergic antidepressants differs from SSRIs due to their 
effect on sleep and specifically their neurotransmission.  SSRIs prevent the reuptake of serotonin 
whereas serotonergic antidepressants (SNRIs) prevent the reuptake of norepinephrine and 
serotonin.  Trazodone has been shown in patients to enhance slow-wave sleep, prolong REM 
latency, and increase total sleep time.  The dose dependent effects of these antidepressants differs 
from study to study.  A study done by van Bemmel and his colleagues reported no change in 
slow-wave sleep.  They concluded that 5% to 9% of their patients underwent REM sleep 
suppression.  Earlier studies used double the amount of trazodone that was done in this particular 
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study.  In 20 of 21 patients that had MAOI-associated insomnia, they reported that the 
administration of trazodone improved their sleep.  Clinically, trazodone is viewed as a sedating 
antidepressant and can have effects in alertness during the day.21  At higher doses, this becomes 
more of a problem as the sedative effects can affect the individual’s performance in daily 
activities.   
 Another serotonergic antidepressant that is widely used includes nefazodone.  
Particularly, this antidepressant is given in 400 mg to 600 mg doses.  Armitage and others report 
that the administration of nefazodone increases stage 2 sleep but has shown to have little to no 
effect on REM sleep.28  In addition, nefazodone decreases awake and movement time during 
sleep, and it also proves to keep individuals in a more relaxed state.  Short duration arousals are 
common for individuals taking this antidepressant.  Nefazodone is different from SSRIs and 
trazodone since it inhibits synaptic uptake of 5-HT and possess 5-HT2 antagonism.  In patients 
that have depression, a reduction in REM sleep is often essential to start seeing anti-depressive 
like behavior.   
 
Alternatives to Antidepressants 
Numerous other treatments may be used instead of antidepressants for treated individuals 
with depression or other mental health conditions.  One of the most popular therapies is known 
as cognitive behavioral therapy.  Cognitive behavioral therapy is a division of psychotherapy that 
relates to changing the thought patterns and behaviors of a certain individual.17  Ultimately, it is 
an interventional that will teach patients how to overcome negative thoughts. Interpersonal 
therapy, exercise, and self-help groups are also helpful options to explore.23  Interpersonal 
therapy is similar to cognitive behavioral therapy, but it will focus on problems one might have 
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having with friends and family members.  Therefore, they might be able to understand the 
difficulties they are having in their relationships and can learn how to better communicate with 
other individuals.  Regular exercise boosts levels of serotonin and dopamine, which will elevate 
your mood.  In addition, self-esteem and confidence can be boosted over time with normalized 
exercise.  Self-help groups are provide individuals another option for depressed individuals.  
Individuals can find ways to support others, keep up with social activities, and reach out to others 
who make them feel safe and secure. 
 Another alternative to investigate is the consumption of omega-3 fatty acids.  Intake of 
omega-6 fatty acids has dramatically increased in the Western diet in the 21st century.  Omega-6 
fatty acids are elongated in the body to form arachidonic acid while omega-3 fatty acids are 
elongated to form eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).  The 
eicosanoids formed when more omega-6 fatty acids are consumed result in more 
proinflammatory eicosanoids.  Blood clotting and inflammation are encouraged because of this.  
On the other hand, an ingestion of more omega-3 fatty acids will result in less proinflammatory 
eicosanoids limiting inflammation and blood clotting.  Ingestion of omega-3 fatty acids is 
believed to reduce cardiovascular risks as well.   
 EPA, a known omega-3 fatty acid, inhibits the synthesis of prostaglandin E2.  This will 
inhibit the synthesis of p-glycoprotein, which is generally considered a useful maker for 
antidepressant resistance.  A study conducted by Peet and Horrobin looked at using ethyl-
eicosapentaenoate for 70 adults who had persistent depression despite already being treated with 
an antidepressant.  They observed a higher response rate in subjects that received 1g/d EPA for 
12 weeks than the other patients who received a placebo.  These results proved to be statistically 
significant as the rate was 53% of the subjects who received EPA to 29% with the other 
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individuals who received a placebo.  There was also remarkable enhancements in depressed 
moods, suicidality, and sleep disturbance.  This study also showed that adults that received more 
than 1 g/d of EPA showed little improvement for a drug to placebo difference.  This might point 
to there being an optimal dose of omega-3 fatty acid intake within humans before a plateau 
occurs.20 
 A study conducted by Frangou and his researchers followed a similar pattern to Peet and 
Horrobin’s study.  They treated 75 depressed individuals with ethyl-eicosapentaenoate at 1 g/d, 2 
g/d, and placebo for 12 weeks.  The EPA group showed to be beneficial based on HAM-D scores 
in comparison to the placebo groups from the experiment.  This study also suggested that the 
higher dose of 2 g/d created no additional benefit when looking back at the 1 g/d group.5   
 
Limitations of Studies 
Circadian factors can alter the effects of antidepressants as pharmacological treatments 
target circadian gene products.11,17  Studies that attempted to inhibit REM sleep are distorted to 
some degree by the timing of the light-dark cycle.  Our circadian rhythm, along with adenosine 
signaling, trigger our body to sleep.  Circadian factors need to be more thoroughly looked at to 
determine if certain genes are altered as well. 
Most omega-3 fatty acid studies are limited to the sample size taken.  Depressive 
evaluation tests performed by patients will offer some variability patient to patient based on the 
rating they give themselves.  Depressive vs manic symptoms also need to be implored in 
research to point which is specifically downregulated in regards to a decrease in REM sleep.  
Some studies grouped depressed patients in one group instead of dividing them out based on the 
condition they were diagnosed with.  Many of the studies showed a small sample size and were 
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not necessarily representative of the whole population of patients who tolerate depressive 
symptoms. 
 
Conclusion 
In regards to alleviating depressive symptoms, a decrease in the overall time in REM 
sleep is clear in many patients.  Longer REM sleep latency and shorter REM duration lead to 
more favorable outcomes.  Many of the antidepressants used today provide an overall 
improvement in alleviating depressive symptoms.  Antidepressants typically have half lives of 24 
hours and are eliminated out of your body within 4-5 days.  Based on preliminary studies, 
tricyclic antidepressants serve to decrease REM sleep time, increase REM sleep latency, and 
show REM sleep rebound over a 72 hour period.  This may serve more favorable outcomes when 
REM sleep time is initially decreased but REM sleep lost can be rebounded.  However, this is 
not the only best-for-all approach solution to fixing all problems.  Prescribing the right 
antidepressant for each patient is also key to the patient’s outcome.  This may be based on 
particular symptoms, interactions with other essential medications, and possible side effects.   
Many side effects due to long term use are seen and cost vs benefit approach needs to be 
explored.  Treatment will not be the exact same for each patient, and many patients will need 
multiple treatment options to experience relief.  A combined treatment approach may improve 
the patient’s quality of life since it is not always one simple fix to improve each patient’s overall 
quality of life.  Patients typically still have to take antidepressants up to one year after depressive 
symptoms seem to be eliminated.  Focusing on lifestyle changes for the individual during that 
time as well may improve quality of life faster them as they transition their outlook.  More 
personalization and medical advances in the future will provide individuals with better outcomes.   
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Future Work 
Further work should be done to examine how the circadian rhythm and REM sleep homeostasis 
interact to help provide a mechanism of REM sleep regulation. Many of the studies conducted 
will need to have a certain depressive symptom common in all individuals and need to evaluate 
how much alleviation occurs.  Universal wide depressive scales based on the disorder need to be 
developed in order to get more accurate and precise results. 
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